Filter
95
Filtered Results: 95
Text search:
reporting
ADRs
Featured
Recommendations
11
New Publications
39
Language
Document type
No document type
59
Guidelines
14
Studies & Reports
11
Strategic & Response Plan
3
Fact sheets
3
Manuals
2
Training Material
1
Brochures
1
Situation Updates
1
Countries / Regions
Ethiopia
8
Kenya
7
Philippines
5
Uganda
5
Ghana
4
Nigeria
4
South Africa
4
India
4
Nepal
3
Sierra Leone
3
Malawi
3
Namibia
3
Lesotho
2
Rwanda
2
Bangladesh
2
Botswana
2
Indonesia
2
Thailand
1
Gambia
1
Zimbabwe
1
Global
1
Cambodia
1
Asia
1
Venezuela
1
Tanzania
1
South–East Asia Region
1
Western and Central Europe
1
Eastern Europe
1
Georgia
1
Zambia
1
Liberia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
35
Policies & Guidelines HIV & TB
19
Guidelines
16
Policies
9
Capacity Building
5
Studies & Reports
4
Pharmaceutical Assessments
3
Women & Child Health
2
Statistics
2
Digital Health
1
Pharmacy & Technology
1
COVID-19
1
Monitoring & Evaluation
1
Countries
1
Community Health
1
Humanitarian Crisis
1
Laboratory Quality Assurance
1
Age & Elderly
1
Toolboxes
Rational use of Medicine
11
Pharmacovigilance
9
Pharmaceutical Assessments
3
Ethiopia
2
Quality Assurance
2
Traditional & Herbal Medicines
2
SEAR (South-east Asia Region)
2
ART Drug Resistance
1
National Policies
1
Treatment Guidelines HIV
1
Namibia
1
Tools for Rational use
1
Georgia
1
Drug resistance
1
Country Guidelines
1
Epilepsy
1
Country Specific
1
Country specific documents
1
Access & Strategy
1
Logistics & Supply
1
Vaxzevria (Astra Zeneca)
1
Pocket Cards
1
Essential Medicines & Devices Lists
1
Pharmacy Practice
1
General Guidelines for Rational Use
1
Detection & Diagnosis
1
Drug resistant TB
1
Liberia
1
Alzheimer's Disease & Dementia
1
Disease Prevention & Control
1
Nutrition
1
General Public
1
Western & Central Europe
1
Antiretroviral Treatment ART
1
Reports & Studies Children HIV
1
Kenya
1
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
(updated December 2014).
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Some of the key findings of the report include:
Almost 80% of the general public are concerned about developing dementia at some point and 1 in 4 people think that there is nothing we can do to prevent dementia
35% of carers across the world said that they have hidden the diagnosis of de...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Accessed November, 2017
